The Current Ratio as of December 2025 (TTM) for Grace Therapeutics, Inc. (GRCE) is 13.89

According to Grace Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 13.89. This represents a change of 36.94% compared to the average of 10.15 of the last 4 quarters.

Grace Therapeutics, Inc. (GRCE) Historical Current Ratio (quarterly & annually)

How has GRCE Current Ratio performed in the past?

The mean historical Current Ratio of Grace Therapeutics, Inc. over the last ten years is 11.57. The current 13.89 Current Ratio has changed 11.91% with respect to the historical average. Over the past ten years (40 quarters), GRCE's Current Ratio was at its highest in in the March 2020 quarter at 39.50. The Current Ratio was at its lowest in in the September 2018 quarter at 0.56.

Grace Therapeutics, Inc. (GRCE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Grace Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Grace Therapeutics, Inc. (GRCE) Average Current Ratio

How has GRCE Current Ratio performed in the past?

The current Current Ratio of Grace Therapeutics, Inc. (GRCE) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Grace Therapeutics, Inc. (GRCE) Current Ratio vs. Peers

How is GRCE’s Current Ratio compared to its peers?

Grace Therapeutics, Inc.’s Current Ratio is greater than LAVA Therapeutics N.V. (10.78), greater than Tvardi Therapeutics, Inc. (3.48), greater than Actinium Pharmaceuticals, Inc. (7.96), greater than PDS Biotechnology Corporation (2.09), greater than CalciMedica, Inc. (4.04), greater than Xilio Therapeutics, Inc. (2.20), greater than Lantern Pharma Inc. (3.52), greater than OnKure Therapeutics, Inc. (11.45), greater than RenovoRx, Inc. (8.61), greater than ABVC BioPharma, Inc. (0.63),

Build a custom stock screener for Grace Therapeutics, Inc. (GRCE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Grace Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Grace Therapeutics, Inc. (GRCE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Grace Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.